The Biotech Sector
Strategic Support for Biotech SMEs: Marketing, Fundraising, and Market Access
In a B2B environment undergoing rapid technological and regulatory change, biotech SMEs face specific challenges: long innovation cycles, a need for ongoing funding, strict scientific and regulatory compliance, and the need to win over demanding stakeholders. Maia Consulting supports these high-potential companies by providing targeted marketing expertise and practical solutions to accelerate their growth.
Our support is built around key drivers: clear and credible strategic positioning, scientific communication based on validated results (publications, trials, clinical evidence), and a structured market access strategy (pre-commercialization, investor outreach, and digitization of awareness-raising initiatives).
Our consultants specializing in biotech digital marketing also address cross-functional priorities for B2B SMEs: investor pitches, marketing automation for complex sales cycles, the creation of accessible yet accurate content, and the alignment of marketing and business development teams. Maia Consulting thus helps biotech companies strengthen their visibility, engage the right influencers, and generate qualified leads in a competitive environment.
Our mission: to provide biotech SMEs with a customized, sustainable, and results-oriented strategy to transform their innovations into tangible and sustainable growth in the most promising markets.
Our Marketing and Strategy Support for Biotech Companies:
Strategy & Positioning
- We analyze your competitive landscape, identify the profiles of investors, influencers, and payers, and develop a strong UVP.
- Our approach helps you maximize your project's appeal to investors.
- We conduct market analyses and assist you with new product launches by helping you identify products to develop, always in collaboration with your scientific teams.
Communication & KOL Influence
- We structure your messaging around clinical evidence and medical expectations.
- We implement marketing and communications strategies tailored to the industry’s very strict legal requirements.
- We engage thought leaders, leverage the right channels, and create clear communications to strengthen your credibility with key stakeholders in the healthcare system.
- We develop a strong investor pitch: scientific storytelling, market-oriented messaging, and a pitch deck designed to meet the expectations of funds specializing in healthcare and biotech.
Market Access & Industry Partnerships
- We are charting a clear path to market and reimbursement for your new therapy.
- By identifying the factors that major pharmaceutical companies look for: clinical evidence, differentiation, and medical-economic value.
Our Network of Biotech Experts
Our mission: to provide personalized, immediately actionable support to biotech companies by combining a differentiation strategy, scientific credibility, and market performance.
We also draw on a committee of life sciences experts, which enriches our strategic thinking and supports the identification and engagement of key opinion leaders (KOLs) in the sector.
Finally, we have a large network of freelance experts specializing in biotechnology who are ready to be called upon ; we mobilize them on demand to address your specific challenges with agility, precision, and efficiency.
Members of our Life Sciences Expert Committee
Denis Dufrane
A pioneer in regenerative medicine, Denis Dufrane is the CEO and founder of Novadip Biosciences, a Belgian biotech company at the forefront of 3D therapies for bone and skin regeneration. With a career at the intersection of translational research and entrepreneurship, he has transformed discoveries in stem cell and tissue engineering into innovative clinical solutions, particularly for severe burns and complex bone defects.
Pierre-François Migeotte
As a physicist (PhD) turned entrepreneur, I founded and led HeartKinetics, a MedTech spin-off specializing in cardiac telemonitoring, from the initial idea through clinical trials and international partnerships. The result: over €4 million raised, a connected solution validated by the Mayo Clinic, and a journey at the heart of medical innovation.
Since then, I’ve been supporting high-potential projects in health technology: proof of concept, market access strategy, fundraising, regulatory filings, and investor pitches. My motto: turning science into impact—no bullshit, but with method, networking, and commitment.
I’m joining the Life Sciences Committee to share this hands-on experience and help entrepreneurs gain momentum, credibility, and tangible results.
Olivier Decuypere
Experienced executive in the MedTech sector, with over 20 years of experience in Europe and emerging markets. Strong track record in strategic management, business leadership, and marketing. Passionate about developing high-impact teams, innovation, and value-driven strategies. Experience in various therapeutic areas such as general surgery (colorectal, bariatric), urogynecology, orthopedics, cardiology, and the management of intraoperative bleeding.
They trust us:
